Gilead Sciences

FILE PHOTO: The coronavirus disease (COVID-19) outbreak in Cairo

India Bans Exports of Antiviral Drug Remdesivir as COVID-19 Cases Surge

Reuters 11/04/2021

Seven Indian companies have licensed the drug from Gilead...

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19), in California

Gilead’s Remdesivir Gets US FDA Approval for Hospitalised COVID-19 Patients

Deena Beasley 23/10/2020

Gilead said it is still working to understand the...

FILE PHOTO: The coronavirus disease (COVID-19) outbreak in Cairo

COVID-19: Remdesivir Caught in Storm After Poor WHO Trial Results and EU Deal

The Wire Staff 17/10/2020

The EU has been advised to renegotiate a 1...

FILE PHOTO: An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news conference

Remdesivir Shows No Benefits Against COVID-19 in Large WHO Trial

Reuters 16/10/2020

The antiviral medication, among the first to be used...

Screenshot 2020-10-07 at 8.37.58 AM

Medicine Nobel for Hep C Should Force Us to Think About Patents, Patients, Profits

Vasudevan Mukunth 07/10/2020

The intertwined stories of HCV infections and sofosbuvir illustrate...

Now, Sun Pharma to Sell COVID-19 Drug Favipiravir in India

Reuters 04/08/2020

Sun's version of favipiravir, to be called FluGuard, will...

A pharmacist displays an ampoule of Dexamethasone at the Erasme Hospital amid the coronavirus disease (COVID-19) outbreak, in Brussels

Preliminary Results Suggest Dexamethasone Could Cut COVID-19 Mortality

Kate Kelland and Alistair Smout 17/06/2020

It is important that the data be released and...